Promoting awareness, pioneering research and providing support and information for those affected by Gaucher disease.
Need support today?
NEED SUPPORT TODAY?
TELEPHONE: 01453 549231
HG Shire Announces FDA Approval of VPRIVTM (velaglucerase alfa for injection) for the Treatment of Type 1 Gaucher Disease
Click here to see full press release: Press Release